Want to see TLSI full AI Analyst Report?
TriSalus Life Sciences (TLSI) Ownership - Who Owns TriSalus Life Sciences?
TriSalus Life Sciences (TLSI) Ownership Overview
- 28.15% Insiders
- 5.99% Mutual Funds
- 0.15% Other Institutional Investors
- 6.73% ETFs
- 58.98% Public Companies and Individual Investors
The ownership structure of TriSalus Life Sciences (TLSI) stock is a mix of institutional, retail, and individual investors. Approximately 12.87% of the company’s stock is owned by Institutional Investors, 28.15% is owned by Insiders, and 58.98% is owned by Public Companies and Individual Investors.
The ownership structure of TriSalus Life Sciences (TLSI) stock is a mix of institutional, retail, and individual investors. Approximately 6.15% of the company’s stock is owned by Institutional Investors, 28.15% is owned by Insiders, and 6.73% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 18, 2026 | Marshak Richard | $1,450 | |
| May 17, 2026 | Michael Stansky | $1,525,000 | |
| May 17, 2026 | Mats Wahlstrom | $151,800 | |
| May 17, 2026 | David Patience | $17,253 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Gilder Gagnon Howe & Co Llc. | $3,867,869 | |
| Jun 30, 2026 | $12,099,442 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Frankenius Equity Ab | 6,989,748 | Insider | 11.35% | 25,862,068 |
| Mats Wahlstrom | 2,962,030 | Insider | 4.81% | 10,959,511 |
| Hicks Kerry R | 2,317,400 | Insider | 3.76% | 8,574,380 |
| Vanguard | 1,988,084 | Institution | 3.23% | 7,355,911 |
| Vanguard Index Funds | 1,687,635 | Institution | 2.74% | 6,244,250 |
| Ishares | 1,645,865 | Institution | 2.67% | 6,089,701 |
| Michael Stansky | 1,640,420 | Insider | 2.66% | 6,069,554 |
| David Matlin | 1,323,210 | Insider | 2.15% | 4,895,877 |
| Mary Szela | 1,077,683 | Insider | 1.75% | 3,987,427 |
| Travis Knapp Anderson | 850,081 | Institution | 1.38% | 3,145,300 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,687,635 | Institution | 2.74% | 6,244,250 |
| Fidelity Salem Street Trust | 566,446 | Institution | 0.92% | 2,095,850 |
| Fidelity Concord Street Trust | 412,979 | Institution | 0.67% | 1,528,022 |
| Vanguard Scottsdale Funds | 330,225 | Institution | 0.54% | 1,221,833 |
| Royce Fund | 200,000 | Institution | 0.32% | 740,000 |
| Schwab Capital Trust | 116,669 | Institution | 0.19% | 431,675 |
| Goldman Sachs Trust | 108,881 | Institution | 0.18% | 402,860 |
| Bridgeway Funds, Inc. | 65,000 | Institution | 0.11% | 240,500 |
| Tiaa-cref Funds | 63,898 | Institution | 0.10% | 236,423 |
| Vanguard Valley Forge Funds | 21,096 | Institution | 0.03% | 78,055 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,141,870 | Institution | 1.85% | 4,921,460 |
| iShares | 1,096,757 | Institution | 1.78% | 4,233,482 |
| Vanguard | 537,051 | Institution | 0.87% | 2,314,690 |
| iShares | 422,334 | Institution | 0.69% | 1,562,636 |
| Invesco | 298,739 | Institution | 0.49% | 1,105,334 |
| Vanguard | 256,597 | Institution | 0.42% | 1,105,933 |
| iShares | 133,088 | Institution | 0.22% | 513,720 |
| Bridgeway | 63,256 | Institution | 0.10% | 244,168 |
| Vanguard | 48,188 | Institution | 0.08% | 207,690 |
| SPDR | 28,098 | Institution | 0.05% | 108,458 |
FAQ
Who Owns TriSalus Life Sciences (TLSI)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 28.15% is held by insiders, and 58.98% is held by retail investors.
What percentage of TriSalus Life Sciences (TLSI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.15% of TriSalus Life Sciences (TLSI) stock is held by institutional investors.
What percentage of TriSalus Life Sciences (TLSI) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.98% of TriSalus Life Sciences (TLSI) stock is held by retail investors.
Who owns the most shares of TriSalus Life Sciences (TLSI)?
Frankenius Equity AB owns the most shares of TriSalus Life Sciences (TLSI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.